Share this article
Share this article
BOSTON, April 6, 2021 /PRNewswire/ Droplette, a clinically-validated breakthrough skincare delivery system that transforms dermatologist-recommended skincare ingredient serums into a powerful micro-mist, has officially launched. A recent NewBeauty 2021 award winner for the Innovations category, Droplette, allows for the effective delivery of skincare deep into the skin, delivering molecules that are 10,000x larger than what could traditionally be absorbed by your skin topically, achieving this feat without needles or pain. This patented technology can effectively help achieve results at home that were previously only possible through treatments with a dermatologist.
Droplette
Droplette can cross the skin barrier that most topical skincare creams and serums can t. In fact, 90% of skincare ingredients applied topically never absorb beyond the surface of your skin. The skin s outer layer does a remarkable job at protecting the body again
R2 Technologies Receives Final Tranche of $30M Investment to Launch Revolutionary Glacial Rx™ and Glacial Spa™ Aesthetic Skin Treatments
News provided by
Share this article
Share this article
SAN RAMON, Calif., Feb. 3, 2021 /PRNewswire/ R2 Technologies Inc. ( R2 ) has received $10 million in funding from Huadong Medicine Company Limited ( Huadong ) as the third and final tranche of Huadong s $30 million Series B equity investment. R2 s post-money valuation is $113 million which is a predetermined valuation established at the time of the Company s Series B close in June 2019. The funds will be used to launch R2 Technologies first to market innovations: Glacial Rx™ is the first revolutionary CryoAesthetic™ age spot removal treatment, FDA-cleared to remove benign lesions and temporarily reduce pain, swelling and inflammation; and Glacial Spa™ is a unique cooling experience that brightens and evens skin tone.